Nanoform Finland Plc, a nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, have partnered to explore synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms. This collaboration aims to provide the pharmaceutical industry with new capabilities in patient centric therapies.   The product innovation target is to combine Nanoform’s fast dissolution nanoformed particles with Aprecia’s ZipDos...